<PAGE> 1
--------
FORM 3
--------
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a)
of the Public Utility Holding Company Act of 1935 or Section 30(f)
of the Investment Company Act of 1940
<TABLE>
<S> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person 2. Date of Event Requiring 4. Issuer Name and Ticker or
Statement Trading Symbol
---------------------------------------- (Month/Day/Year) Sybron Chemicals Inc. (AMEX:SYC)
(Last) (First) (Middle) 8/30/00 -----------------------------------------------------------
---------------------------- 5. Relationship of Reporting 6. If Amendment, Date
Bayer Corporation 3. IRS or Social Security Person to Issuer of Original
---------------------------------------- Number of Reporting (Check all applicable) (Month/Day/Year)
(Street) Person (Voluntary) X 7. Individual or Joint/
----- Director ----- 10% Owner Group Filing (Check
100 Bayer Road ---------------------------- Applicable Line)
---------------------------------------- ----- Officer ----- Other (specify
(City) (State) (Zip) (give title below) below) -- Form filed by One
President Reporting Person
Pittsburgh PA 15205 --------------------------- X
-- Form filed by
More than One
Reporting Person
-----------------------------------------------------------------------------------------------------------------------------------
TABLE I -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
-----------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Amount of Securities 3. Ownership Form: 4. Nature of Indirect
(Instr. 4) Beneficially Owned Direct (D) or Beneficial
(Instr. 4) Indirect (I) Ownership (Instr. 5)
(Instr. 5)
-----------------------------------------------------------------------------------------------------------------------------------
Common Stock, par value $.01 per share 0(1) N/A
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
--------------
(1) See note 1 on page 2.
</TABLE>
<PAGE> 2
FORM 3 (CONTINUED)
TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security 2. Date 3. Title and Amount of 4. Conver- 5. Owner- 6. Nature of Indirect
(Instr. 4) Exercisable and Securities Underlying sion or ship Beneficial Ownership
Expiration Date Derivative Security Exercise Form of (Instr. 5)
(Month/Day/ (Instr. 4) Price of Deriv-
Year) Deri- ative
vative Security:
Security Direct (D)
------------------------------------------------- or
Date Expira- Amount or Indirect (I)
Exercis- tion Title Number (Instr. 5)
able Date of Shares
<S> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
(1) On August 30, 2000, Bayer Corporation, an Indiana corporation and a wholly owned subsidiary of Bayer Aktiengesellschaft
("Parent"), and Project Toledo Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (the
"Purchaser"), entered into a Stockholder Agreement (the "Stockholder Agreement") with 399 Venture Partners, Inc., Richard M.
Klein and John H. Schroeder (each a "Stockholder" and, collectively the "Stockholders") pursuant to which each Stockholder has
agreed, among other things, to tender the Shares (as defined below) owned by such Stockholder into the Purchaser's offer to
purchase all the outstanding shares of common stock, par value $.01 per share (the "Shares"), of Sybron Chemicals Inc., a
Delaware corporation (the "Company"), together with the associated rights to purchase Series A Junior Participating Preferred
Stock pursuant to the rights agreement by and between the Company and Fleet National Bank, as rights agent, as amended as of
August 30, 2000. Under the Stockholder Agreement, each Stockholder has granted to certain individuals designated by Parent
an irrevocable proxy with respect to the Shares subject to the Stockholder Agreement to vote such Shares under certain
circumstances. See Joint Filer Information on attached page.
**Intentional misstatements or omissions of facts constitute Federal Criminal /s/ E.L. Foote, Jr. September 8, 2000
Violations. ------------------------------- -----------------
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Name: E.L. Foote, Jr. Date
Title: Executive Vice President
Note: File three copies of this Form, one of which must be manually signed. **Signature of Reporting Person
If space is insufficient, See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
</TABLE>
Page 2 of 3 pages
<PAGE> 3
JOINT FILER INFORMATION
Title of Securities: Common Stock, par value $0.01 per share
Issuer & Ticker Symbol: Sybron Chemicals Inc. (SYC)
Designated Filer: Bayer Corporation
Other Joint Filers:
Project Toledo Acquisition Corp.
100 Bayer Road
Pittsburgh, PA 15205-9741
Bayer Aktiengesellschaft
D-51368 Leverkusen
Germany
Date of Event
Requiring Statement: August 30, 2000
PROJECT TOLEDO ACQUISITION CORP.,
by /s/ John L. Williams
------------------------------
Name: John L. Williams
Title: President
BAYER AKTIENGESELLSCHAFT,
by /s/ Roland Hartwig
------------------------------
Name: Dr. Roland Hartwig
Title: General Counsel
Page 3 of 3 pages
